यूरोपीय संघ - लातवियाई - EMA (European Medicines Agency)

extrovis eu ltd. - sugammadex sodium - neiromuskulārā blokāde - visi pārējie terapeitiskie produkti - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

लातविया - लातवियाई - Zāļu valsts aģentūra

kalceks, a/s, latvia - sugammadekss - Šķīdums injekcijām - 100 mg/ml